TP53 and neoplasm: The expression levels of several genes regulating drug-mediated and p53-mediated apoptosis, the proliferative and migratory properties of tumor cells, and the recruitment of immune cells to the tumor allowed the differentiation of patients into high- and low-risk groups [80,81,82,83,84].